These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3712034)

  • 1. Hormonal manipulation of meningiomas in vitro.
    Olson JJ; Beck DW; Schlechte J; Loh PM
    J Neurosurg; 1986 Jul; 65(1):99-107. PubMed ID: 3712034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of meningioma cell growth by sex steroid hormones in vitro.
    Jay JR; MacLaughlin DT; Riley KR; Martuza RL
    J Neurosurg; 1985 May; 62(5):757-62. PubMed ID: 3989596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice.
    Olson JJ; Beck DW; Schlechte JA; Loh PM
    J Neurosurg; 1987 Apr; 66(4):584-7. PubMed ID: 3559725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
    Grunberg SM; Weiss MH; Spitz IM; Ahmadi J; Sadun A; Russell CA; Lucci L; Stevenson LL
    J Neurosurg; 1991 Jun; 74(6):861-6. PubMed ID: 2033444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
    Lamberts SW; van Koetsveld P; Verleun T
    Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
    Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
    J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone (RU 486) treatment of meningiomas.
    Lamberts SW; Tanghe HL; Avezaat CJ; Braakman R; Wijngaarde R; Koper JW; de Jong H
    J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):486-90. PubMed ID: 1619417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture.
    Waelti ER; Markwalder TM
    Surg Neurol; 1989 Feb; 31(2):96-100. PubMed ID: 2522246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of steroids and antisteroids on human meningioma cells in primary culture.
    Blankenstein MA; van der Meulen-Dijk C; Thijssen JH
    J Steroid Biochem; 1989; 34(1-6):419-21. PubMed ID: 2626036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antiprogestational therapy for meningiomas.
    Grunberg SM
    Hum Reprod; 1994 Jun; 9 Suppl 1():202-7. PubMed ID: 7962466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy.
    Schrell UM; Adams EF; Fahlbusch R; Greb R; Jirikowski G; Prior R; Ramalho-Ortigao FJ
    J Neurosurg; 1990 Nov; 73(5):743-9. PubMed ID: 2213164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols.
    Markwalder TM; Waelti E; König MP
    Surg Neurol; 1987 Jul; 28(1):3-9. PubMed ID: 2954242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486).
    Touat M; Lombardi G; Farina P; Kalamarides M; Sanson M
    Acta Neurochir (Wien); 2014 Oct; 156(10):1831-5. PubMed ID: 25078073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progestin receptors in meningiomas: clinicopathological correlations.
    Markwalder TM; Markwalder RV; Zava DT
    Clin Neuropharmacol; 1984; 7(4):368-74. PubMed ID: 6509449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
    Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
    Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
    Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
    Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.